You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

Richter's syndrome, Burkitt's lymphoma, or Burkitt-like Lymphoma (transformed DLBCL from Follicular NHL are eligible). 
Prior transplant with stem cell infusion 90 days or active graft-versus-host treatment within 8 weeks of Day 1. 
Prior therapy with SYK inhibitors. 
Chronic treatment with strong CYP3A4 inhibitor/ inducer, acid reducing agent, Proton pump inhibitors 
Known lymphomatous involvement of the CNS. 
Persistent, unresolved NCI CTCAE v4.0 ≥ Grade 2, previous drug-related toxicity (except alopecia, erectile impotence, hot flashes, libido, neuropathy). 
Prior monoclonal antibody, radioimmunoconjugate, antibody drug conjugate, phototherapy, radiotherapy, chemotherapy, immunotherapy, immunosuppressive therapy, or any test agent within 3 weeks or for alemtuzumab 8 weeks of Day 1. 
For CTCL: (TSEBT) within 12 weeks, or initiation of topical steroid, nitrogen mustard, or topical retinoid within 2 weeks. (Stable topical ≥ 4 weeks prior to Day 1 allowed). 
Known carrier or infection for HIV/Hep B or C. HCV ab+ must be PCR-. HBV ab+ must be HBsAg- or undetectable DNA 
Active infection requiring systemic treatment, 
Significant GI disease, previous major gastric/bowel surgery, difficulty swallowing or malabsorption syndrome. 
Major surgery within 4 weeks 
Previous malignancies within 2 yrs. unless relapse risk is small (< 5%). 
Current use of systemic steroids >20 mg QD prednisone (or equivalent) 
Breastfeeding or pregnant (intention to become) females or participation in other clinical trials
{"Condition": ["Hep B infection for", "HBV ab+", "drug-related toxicity", "malignancies", "neuropathy", "infection", "difficulty swallowing", "CTCL", "hot flashes", "Richter\u0027s syndrome", "DLBCL", "erectile impotence", "Burkitt-like Lymphoma", "GI disease", "Follicular NHL", "undetectable DNA", "Burkitt\u0027s lymphoma", "lymphomatous involvement of the CNS", "alopecia", "libido", "malabsorption syndrome", "pregnant", "Hep C infection for", "infection for HIV", "HCV ab+"], "Device": [], "Drug": ["topical retinoid", "topical steroid", "Proton pump inhibitors", "strong CYP3A4 inhibitor", "SYK inhibitors", "prednisone", "monoclonal antibody", "radioimmunoconjugate", "antibody drug conjugate", "systemic steroids", "strong CYP3A4 inducer", "alemtuzumab", "acid reducing agent", "nitrogen mustard"], "Measurement": ["NCI CTCAE v4.0"], "Mood": [], "Multiplier": ["\u003e20 mg QD"], "Negation": ["except"], "Observation": ["initiation", "Breastfeeding"], "Person": ["females"], "Procedure": ["phototherapy", "bowel surgery", "radiotherapy", "immunotherapy", "gastric surgery", "graft-versus-host treatment", "chemotherapy", "systemic treatment", "stem cell infusion", "surgery", "immunosuppressive therapy", "transplant", "therapy", "TSEBT"], "Qualifier": ["Major", "Significant", "PCR-", "major", "requiring systemic treatment", "HBsAg-"], "ReferencePoint": ["Day 1"], "Scope": ["within 3 weeks or for alemtuzumab 8 weeks of Day 1", "gastric/bowel surgery", "topical steroid, nitrogen mustard, or topical retinoid", "monoclonal antibody, radioimmunoconjugate, antibody drug conjugate, phototherapy, radiotherapy, chemotherapy, immunotherapy, immunosuppressive therapy", "infection for HIV/Hep B or C", "alopecia, erectile impotence, hot flashes, libido, neuropathy"], "Temporal": ["within 2 yrs.", "\u2265 4 weeks prior to Day 1", "90 days of Day 1", "Prior", "within 8 weeks of Day 1", "8 weeks of Day 1", "within 12 weeks", "within 4 weeks", "active", "within 2 weeks", "within 3 weeks of Day 1", "previous"], "Value": ["\u2265 Grade 2"], "Visit": []}